Loading
Inspire Medical Systems, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Curet Myriam, was filed 24 Nov 2025.
Insider Decl.
1,114
Thresholds
n/a
Buy Volume
€10M
14 ops. · all time
Sell Volume
€606M
505 ops. · all time
Who traded when
BuySaleBan Randy13 sales
John Rondoni10 sales
Curet Myriam2 buys2 sales
mcCormick Shawn3 sales
Buchholz Richard1 sale
Jason P. Kelly1 sale
Since the insiders bought
- -55.3%Entry US$130.39 · Close at T+90 US$58.29
- -11.5%Entry US$213.05 · Close at T+365 US$188.47
- +99.8%Entry US$25.51 · Close at T+365 US$50.98
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Inspire Medical Systems, Inc. Hold (neutral), based on 16 analysts. Average price target: US$68.00.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 5,062 of 26,250 companies
67.4
score / 100
Value50
Quality85
FCF yld3.8%
Earn yld7.1%
EV/EBITDA26.2x
ROE18%
Gross mgn85%
Net mgn16%
Debt/EBITDA0.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$71.07
Analyst consensus
16 analystsHold
US$40.00Target US$68.00(-4%)US$97.00
Income statement
RevenueUS$912M
Gross profitUS$778.8M85% margin
EBITDAUS$79.8M9% margin
Net incomeUS$145.4M15.0% margin
Valuation
PER (trailing)15.7x
PER (forward)46.3x
P/Book2.5x
Beta0.73
Balance sheet & cash
Market capUS$2.1B
Total debtUS$32.2M
Free Cash FlowUS$78.5M
Debt / Equity4%
Profitability & ownership
ROE18.0%
ROA3.9%
% insiders1.2%
% institutions129.4%
Last declaration on 16 October 2026
Declarations1,114 total
431 shares@ US$68.070.0015% mcap7.2% of flowCommon StockSEC:0001104659-26-116648:0
255 shares@ US$68.070.0009% mcap4.3% of flowCommon StockSEC:0001104659-26-116647:0
203 shares@ US$68.070.0007% mcap100.0% of flowCommon StockSEC:0001104659-26-116645:0
284 shares@ US$68.070.0010% mcap17.7% of flowCommon StockSEC:0001104659-26-116643:0
64 shares@ US$62.360.0002% mcap100.0% of flowCommonSEC144:0001950047-26-008598
963 shares@ US$59.550.0028% mcap64.2% of flowCommon StockSEC:0001104659-26-094238:0
963 shares@ US$59.5450.0028% mcap100.0% of flowCommonSEC144:0001950047-26-007782
326 shares@ US$124.54Common StockSEC:0001104659-26-090595:0
326 shares@ US$50.210.0008% mcap31.5% of flowCommon StockSEC:0001104659-26-090595:1
5,631 shares0Common StockSEC:0001104659-26-087217:0
581 shares0Common StockSEC:0001104659-26-084765:0
344 shares0Common StockSEC:0001104659-26-084767:0
383 shares0Common StockSEC:0001104659-26-084764:0
346 shares0Common StockSEC:0001104659-26-084766:0
700 shares@ US$43.010.0018% mcap0.8% of flowCommon StockSEC:0001104659-26-062498:0
518 shares@ US$52.070.0018% mcap6.8% of flowCommon StockSEC:0001104659-26-044367:0
307 shares@ US$52.070.0011% mcap3.9% of flowCommon StockSEC:0001104659-26-044368:0
342 shares@ US$52.070.0012% mcap18.9% of flowCommon StockSEC:0001104659-26-044369:0
308 shares@ US$52.070.0011% mcap5.3% of flowCommon StockSEC:0001104659-26-044359:0
15,958 shares0Common StockSEC:0001104659-26-019273:2
15,958 shares0Common StockSEC:0001104659-26-019288:2
8,399 shares0Common StockSEC:0001104659-26-019288:3
20,997 shares0Common StockSEC:0001104659-26-019275:2
12,598 shares0Common StockSEC:0001104659-26-019275:3
62,153 shares0Common StockSEC:0001104659-26-019289:2
25 of 1114 declarations
About Inspire Medical Systems, Inc.
On May 7, 2018, the first day of Inspire Medical Systems, Inc.'s record, 12 filers bought together for EUR 15,494,886, which is nearly all of the 16 purchases (EUR 15.5 million in all, median EUR 51,954, 3% of open-market trades). Orbimed Advisors LLC (10% Owner) and Chau Quang Khuong (Director) each bought EUR 4,189,800, Casey M. Tansey (Director) EUR 2,513,880; 13 filings are marked as clustered.
The 519 sales weigh EUR 575.2 million, with a median of EUR 255,553. Orbimed Advisors LLC, filed as Director, sold EUR 37,206,488 on March 6, 2020 and EUR 30,301,377 on March 3, 2020; Chau Quang Khuong EUR 30,202,099 on March 4, 2020.
Read moreShow less
Timothy P. Herbert (CEO and President) signs 151 of the 1,111 filings, 86 of them sales and 1 a purchase; Randy Ban (See Remarks) 146, with 102 sales; Richard Buchholz (Interim CFO) 134. Yearly volume goes from 231 in 2019 to 67 in 2021, then 182 in 2023 and 52 in 2026. There are 274 grants, 150 option exercises and 152 filings of another kind. The US healthcare and pharma company is worth USD 2.03 billion, with 1.2% held by insiders. Last twelve months: 58 filings, 2 purchases, 7 sales. The median publication delay is 2 days.
